Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;81(5):542-555.
doi: 10.1111/his.14722. Epub 2022 Aug 4.

Serous tubal intra-epithelial carcinoma: what do we really know at this point?

Russell Vang  1   2 , Ie-Ming Shih  1   2   3
Affiliations
Review

Serous tubal intra-epithelial carcinoma: what do we really know at this point?

Russell Vang et al. Histopathology. 2022 Nov.

Abstract

Serous tubal intra-epithelial carcinoma (STIC) is the earliest morphologically recognisable step in the development of invasive high-grade serous carcinoma of the fallopian tube. Lesions occurring prior to STIC within the carcinogenic sequence for the pathogenesis of invasive high-grade serous carcinoma include the p53 signature and secretory cell outgrowth (SCOUT). Variable histological criteria have been used for diagnosing STIC, but a combination of morphology and immunohistochemistry for p53/Ki-67 improves interobserver agreement. Half of all carcinomas identified in risk-reducing salpingo-oophorectomy specimens are in the form of STIC; however, STIC also may be incidentally found on occasion in specimens from women at low or average risk of ovarian/tubal/peritoneal carcinoma. TP53 mutation is the earliest known DNA sequence alteration in STIC and almost all invasive high-grade serous carcinomas of the ovary and peritoneum. Data on the clinical behaviour of STIC are limited. While the short-term follow-up in the prior literature suggests a low risk of malignant progression, a more recent meta-analysis indicates a 10-year risk of 28%. STIC probably should be best regarded as a lesion with uncertain malignant potential at present, and future molecular analysis will help to classify those with higher risk of dissemination. This review provides an update on the current knowledge of STIC and related issues.

Keywords: SCOUT; STIC; p53 signature; serous tubal intra-epithelial carcinoma.

PubMed Disclaimer

References

    1. Meserve EEK, Brouwer J, Crum CP. Serous tubal intraepithelial neoplasia: the concept and its application. Mod. Pathol. 2017; 30; 710-721.
    1. Shih IM, Wang Y, Wang TL. The origin of ovarian cancer species and precancerous landscape. Am. J. Pathol. 2021; 191; 26-39.
    1. Soong TR, Kolin DL, Teschan NJ, Crum C. Back to the future? The fallopian tube, precursor escape and a dualistic model of high-grade serous carcinogenesis. Cancers 2018; 10; 468.
    1. Soong TR, Howitt BE, Horowitz N, Nucci MR, Crum CP. The fallopian tube, ‘precursor escape’ and narrowing the knowledge gap to the origins of high-grade serous carcinoma. Gynecol. Oncol. 2019; 152; 426-433.
    1. Vang R. Diseases of the fallopian tube and paratubal region. In Kurman RJ, Ellenson LH, Ronnett BM eds. Blaustein's pathology of the female genital tract. 7th ed. Cham, Switzerland: Springer, 2019.